ML
Maravai Lifesciences Holdings Inc
🇺🇸XNAS.MRVIUnited StatesHealthcare
$6.85USDdown -0.03 (-0.44%)ClosedDelayed10:41 PM
Price$6.85-0.03 (-0.44%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US56600D1072
- CUSIP
- 56600D107
Company
- Employees
- 415
- Headquarters
- San Diego, United States
- Website
- https://www.maravai.com
- CEO
- Mr. Bernd Brust
Market
- Shares outstanding
- 149M
- Market cap
- $1.02B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.03B
- EPS LTM
- -$0.52
- P/E LTM
- -11.76
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $208.78M-3.28%down year on year
- Net income
- -$77.39M+60.26%up year on year
- Gross margin
- 34.61%+18.89%up year on year
- Free cash flow
- -$35.11M+21.47%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.